Selected article for: "antiviral activity and SARS CoV antiviral activity"
Author: Sandra De Meyer; Denisa Bojkova; Jindrich Cinati; Ellen Van Damme; Christophe Buyck; Marnix Van Loock; Brian Woodfall; Sandra Ciesek
Title: Lack of Antiviral Activity of Darunavir against SARS-CoV-2
  • Document date: 2020_4_8
    • ID: 679qfp2s_34
    Snippet: In conclusion, the lack of in vitro antiviral activity of DRV against SARS-CoV-2 does not support the use of DRV for treatment of COVID-19. Hence, the use of DRV (boosted with either ritonavir or cobicistat) should remain solely for treatment of patients with HIV infection. All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity......
    Document: In conclusion, the lack of in vitro antiviral activity of DRV against SARS-CoV-2 does not support the use of DRV for treatment of COVID-19. Hence, the use of DRV (boosted with either ritonavir or cobicistat) should remain solely for treatment of patients with HIV infection. All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • antiviral activity and DRV antiviral activity: 1, 2, 3, 4
    • antiviral activity and HIV infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43
    • antiviral activity and SARS vitro DRV antiviral activity: 1, 2, 3
    • antiviral activity and vitro DRV antiviral activity: 1, 2
    • DRV antiviral activity and SARS vitro DRV antiviral activity: 1, 2, 3
    • DRV antiviral activity and vitro DRV antiviral activity: 1, 2
    • SARS vitro DRV antiviral activity and vitro DRV antiviral activity: 1, 2